Biomateriales y Nanomedicina
BioNanoMed
Centro de Investigaciones Biológicas
Madrid, EspañaCentro de Investigaciones Biológicas-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2017
-
Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells
Cancer Letters, Vol. 388, pp. 262-268